SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 101.87 |
Enterprise Value ($M) | 46.37 |
Book Value ($M) | 215.99 |
Book Value / Share | 3.04 |
Price / Book | 0.47 |
NCAV ($M) | 124.15 |
NCAV / Share | 1.75 |
Price / NCAV | 0.82 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.37 |
Return on Assets (ROA) | -0.26 |
Return on Equity (ROE) | -0.41 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.71 |
Current Ratio | 5.71 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 257.77 |
Assets | 349.60 |
Liabilities | 133.62 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 35.58 |
Operating Income | -117.18 |
Net Income | -105.32 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -65.16 |
Cash from Investing | -51.27 |
Cash from Financing | 45.34 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Morgan Stanley | 5.40 | ||
13G/A | Lynx1 Capital Management LP | 9.90 | 119.52 | |
13G/A | Soleus Capital Master Fund, L.P. | 9.40 | 158.37 | |
13G | Orbimed Advisors Llc | 4.20 | ||
13G/A | Commodore Capital Lp | 4.80 | -10.25 | |
13G/A | Price T Rowe Associates Inc /md/ | 0.60 | -84.68 | |
13G/A | Point72 Asset Management, L.P. | 1.90 | -50.92 | |
13G | BlackRock, Inc. | 7.10 | 0.00 | |
13G/A | State Street Corp | 4.35 | -58.13 | |
13G/A | Wasatch Advisors Inc |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
314,390 | 717,371 | 43.83 | |
348,491 | 817,885 | 42.61 | |
396,266 | 832,412 | 47.60 | |
150,280 | 447,817 | 33.56 | |
(click for more detail) |
Similar Companies | |
---|---|
BMRN – BioMarin Pharmaceutical Inc. | BPMC – Blueprint Medicines Corporation |
CABA – Cabaletta Bio, Inc. | CGC – Canopy Growth Corporation |
CGEM – Cullinan Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io